Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Assessment of BB-02 Therapy Effect on Cartilage Status in Patients Affected by Early Knee Osteoarthritis

NCT06459817 is registered in ClinicalTrials.gov with Stefano Zaffagnini as lead sponsor.

NCT NCT06459817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06459817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Assessment of BB-02 Therapy Effect on Cartilage Status in Patients Affected by Early Knee Osteoarthritis
Lead sponsor
Stefano Zaffagnini
Phase
Not applicable
Overall status
Completed
Start date
July 10, 2024
Completion date
May 12, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee